TY  - CONF

T1  - EXPLORATORY COST EFFECTIVENESS ANALYSIS OF BEVACIZUMAB IN ADDITION TO FOLFOX-4 IN THE ADJUVANT TREATMENT OF STAGE III COLON CANCER: A UK PERSPECTIVE

JO  - VALUE HEALTH

PY  - 2008/11/01

AU  - Ducournau P

AU  - Latimer N

AU  - Sabate E

AU  - Walzer S

ED  - 

VL  - 11

IS  - 6

SP  - A471

EP  - A472

Y2  - 2024/12/22

ER  -